IN2014CN02870A - - Google Patents
Info
- Publication number
- IN2014CN02870A IN2014CN02870A IN2870CHN2014A IN2014CN02870A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A IN 2870CHN2014 A IN2870CHN2014 A IN 2870CHN2014A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A
- Authority
- IN
- India
- Prior art keywords
- proteins
- relates
- kits used
- diagnosis
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/045—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/34—Introducing sulfur atoms or sulfur-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1159348A FR2981352B1 (fr) | 2011-10-17 | 2011-10-17 | Procede de synthese de proteines |
| PCT/EP2012/070454 WO2013057084A1 (fr) | 2011-10-17 | 2012-10-16 | Procede de synthese de proteines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN02870A true IN2014CN02870A (fr) | 2015-07-03 |
Family
ID=47022687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2870CHN2014 IN2014CN02870A (fr) | 2011-10-17 | 2012-10-16 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9206224B2 (fr) |
| EP (1) | EP2768842B1 (fr) |
| JP (1) | JP6321542B2 (fr) |
| CN (1) | CN103998455B (fr) |
| CA (1) | CA2852833A1 (fr) |
| ES (1) | ES2702786T3 (fr) |
| FR (1) | FR2981352B1 (fr) |
| IN (1) | IN2014CN02870A (fr) |
| SG (1) | SG11201401540WA (fr) |
| WO (1) | WO2013057084A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2971509B1 (fr) * | 2011-02-16 | 2013-02-22 | Centre Nat Rech Scient | Procede de preparation de peptides par assemblage de multiples fragments peptidiques |
| CA2918076A1 (fr) | 2013-07-11 | 2015-01-15 | Novartis Ag | Modifications de proteines chimioenzymatiques specifiques d'un site |
| NL2027769B1 (en) | 2021-03-18 | 2022-09-29 | Univ Delft Tech | C-terminal peptide modification |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2218620C (fr) | 1995-05-04 | 2007-02-27 | Stephen B. H. Kent | Synthese de proteines par ligature chimique endogene |
| JP4358307B2 (ja) | 1996-12-24 | 2009-11-04 | ザ スクリップス リサーチ インスティテュート | 一般的化学結合 |
| DE69828287T2 (de) * | 1997-06-13 | 2005-12-15 | Gryphon Therapeutics, Inc., South San Francisco | Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen |
| EP1263771B1 (fr) | 2000-03-16 | 2006-06-14 | The Regents Of The University Of California | Ligature chimioselective en utilisant une phosphine |
| AU2001261530B2 (en) | 2000-05-12 | 2006-11-09 | Wisconsin Alumni Research Foundation | Ligation method and reagents to form an amide bond |
| CA2466746A1 (fr) | 2001-11-14 | 2003-05-22 | Geneprot, Inc. | Ligation peptidique chimique avec au moins trois composants |
| AU2005298840B2 (en) * | 2004-10-26 | 2010-09-16 | Lonza Ag | S-alkyl-sulphenyl protection groups in solid-phase synthesis |
| MX2007009467A (es) * | 2005-02-11 | 2007-10-02 | Merck Patent Gmbh | Etiquetado de oligosacaridos de fase solida: una tecnica para manipulacion de carbohidratos inmovilizados. |
| US7667076B2 (en) | 2005-09-14 | 2010-02-23 | Regents Of The University Of California | Amide forming chemical ligation |
| FR2952058B1 (fr) * | 2009-10-29 | 2013-10-04 | Centre Nat Rech Scient | Procede de ligation native de polypeptides |
| CN102666565B (zh) | 2009-11-16 | 2016-01-20 | 国家科学研究中心 | 用于纯化由固相肽合成法制备的肽的化合物和方法 |
-
2011
- 2011-10-17 FR FR1159348A patent/FR2981352B1/fr not_active Expired - Fee Related
-
2012
- 2012-10-16 CA CA2852833A patent/CA2852833A1/fr not_active Abandoned
- 2012-10-16 JP JP2014536201A patent/JP6321542B2/ja active Active
- 2012-10-16 ES ES12772951T patent/ES2702786T3/es active Active
- 2012-10-16 US US14/352,155 patent/US9206224B2/en not_active Expired - Fee Related
- 2012-10-16 SG SG11201401540WA patent/SG11201401540WA/en unknown
- 2012-10-16 WO PCT/EP2012/070454 patent/WO2013057084A1/fr active Application Filing
- 2012-10-16 IN IN2870CHN2014 patent/IN2014CN02870A/en unknown
- 2012-10-16 EP EP12772951.5A patent/EP2768842B1/fr not_active Not-in-force
- 2012-10-16 CN CN201280062427.3A patent/CN103998455B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2981352A1 (fr) | 2013-04-19 |
| CA2852833A1 (fr) | 2013-04-25 |
| EP2768842B1 (fr) | 2018-07-25 |
| ES2702786T3 (es) | 2019-03-05 |
| SG11201401540WA (en) | 2014-06-27 |
| US20140256879A1 (en) | 2014-09-11 |
| FR2981352B1 (fr) | 2015-07-03 |
| CN103998455A (zh) | 2014-08-20 |
| WO2013057084A1 (fr) | 2013-04-25 |
| JP6321542B2 (ja) | 2018-05-09 |
| US9206224B2 (en) | 2015-12-08 |
| JP2014532075A (ja) | 2014-12-04 |
| CN103998455B (zh) | 2018-05-29 |
| EP2768842A1 (fr) | 2014-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120390T1 (el) | Συνθεση και μεθοδος για διαγνωση και θεραπεια ασθενειων που σχετιζονται με εκφυλισμο νευριτων | |
| CY1122907T1 (el) | Διαγνωστικες αναλυσεις και kit για ανιχνευση υποδοχεα φολικου 1 | |
| EP4327885A3 (fr) | Constructions d'anticorps pour msln et cd3 | |
| EP4282484A3 (fr) | Anticorps bispécifiques dirigés contre cd3epsilon et bcma à utiliser dans le traitement de maladies | |
| NZ760022A (en) | Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor | |
| WO2015061634A3 (fr) | Biomarqueurs et procédés de diagnostic pour la maladie d'alzheimer et d'autres troubles neurodégénératifs | |
| MX2018009304A (es) | Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares. | |
| WO2014124334A3 (fr) | Anticorps anti-transthyrétine et leurs utilisations | |
| NZ718280A (en) | Antibodies against claudin 18.2 useful in cancer diagnosis | |
| MY161291A (en) | Antibody, kit and method for determination of amyloid peptides | |
| EA201690213A1 (ru) | Композиции и способ лечения связанных с комплементом состояний | |
| PH12017500489A1 (en) | Human-derived anti-dipeptide repeats (dprs) antibody | |
| WO2014200912A3 (fr) | Procédés mathématiques pour la détermination du clivage de la peptidase | |
| MX358474B (es) | Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson. | |
| BR112013024213A2 (pt) | instrumento médico e método de sua fabricação | |
| MX2016000393A (es) | Modificaciones de proteinas quimioenzimaticas de lisina utilizando transglutaminasa microbiana. | |
| WO2015013508A3 (fr) | Procédés permettant de diagnostiquer et de traiter une maladie du système immunitaire | |
| WO2014091490A3 (fr) | Diagnostic de maladies auto-immunes utilisant un profil spécifique d'anticorps | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| WO2015001013A3 (fr) | Anticorps anti-ifn-alpha humains | |
| WO2013167727A3 (fr) | Procédé de détermination d'un risque de rechute de l'arthrite | |
| EP3696190A3 (fr) | Procédés | |
| IN2014CN02870A (fr) | ||
| TR201900550T4 (tr) | İnsan p53'ünün bir lineer epitopunu bağlayan antikor ve bunun tanısal uygulamaları. | |
| EA029703B9 (ru) | Новый аллерген из пыльцы амброзии и его применение |